Clinical and demographic factors affecting trough levels of isavuconazole in critically ill patients with or without COVID-19.

Isavuconazole plasma levels can be negatively affected by patients' risk factors, supportive renal replacement and ECMO therapy. Future prospective studies analysing the relevance of isavuconazole drug levels in ICU patient outcome are urgently needed.